“GHOSTWRITTEN” articles commissioned by drug company Wyeth may have led to hormone replacement therapy (HRT) being recommended to healthy menopausal women, despite .
So says Adriane Fugh-Berman of Georgetown University in Washington DC, an expert witness for thousands of women with breast cancer who are suing Pfizer – which acquired Wyeth in 2009 – for damages. She analysed 1500 documents made public through litigation and found controversial statements about the HRT Prempro in dozens of peer-reviewed articles drafted for Wyeth by communications firms. The articles were published under the names of…
